Google DeepMind's $2.1B AI Drug Discovery Boost | OWITH Daily episode artwork

EPISODE · May 28, 2026 · 3 MIN

Google DeepMind's $2.1B AI Drug Discovery Boost | OWITH Daily

from OWITH.ai - Only What's Important to Hear around AI and Tech · host owith.ai

Good morning from OWITH.ai, the podcast that gives you only what's important to hear in the AI and tech world. Demis Hassabis, CEO of Google DeepMind, is on a mission to revolutionize AI-driven drug discovery through his company, Isomorphic Labs. This AI drug discovery startup, spun out of Google in 2021, recently secured a $2.1 billion Series B funding round led by Thrive Capital. The capital aims to propel the company's next phase, focusing on scaling compute capabilities, generating more data, and expanding programs. Despite the hurdles in automating labs and conducting experiments, Hassabis remains optimistic about bridging biology and information science using AI. While no drugs have reached clinical trials yet, several programs are progressing well in the pre-clinical stage. Hassabis highlights the broader goal of addressing all diseases through a robust platform rather than individual drug success. The name "Isomorphic" symbolizes the underlying structural connection between biology and information science. In a lighter moment, he mentions an internal nod to "Tron: Legacy," where employees refer to themselves as "Isos." In addition to these advancements, venture capital activities are bustling with significant funding rounds for companies like Stord and OpenRouter, along with notable IPO plans for Quantinuum and Applied Aerospace & Defense. On May 27, 2026, several significant events unfolded. The Chinese government has introduced restrictions on overseas travel for top AI talent in domestic companies such as Alibaba and DeepSeek. This measure aims to protect China's tech trade secrets amid growing competition with the U.S. Meanwhile, Micron has achieved a valuation over $1 trillion due to a surge driven by the global AI boom. The company is expanding its manufacturing capabilities to address a memory supply crunch. In another development, Dropbox co-founder Drew Houston announced his resignation as CEO after 19 years, with Ashraf Alkarmi stepping in temporarily. Dropbox is now focusing on integrating AI into its services with optimism for future growth. Additional tech news includes American Airlines partnering with Starlink for in-flight Wi-Fi and Qualcomm supplying chips to ByteDance for AI agents. In 2026, Citigroup CEO Jane Fraser has been recognized for her efforts to restore the bank's credibility, earning her the top spot on Fortune's Most Powerful Women list. Her leadership transformation has positively impacted Citigroup's stock price. The list also highlights influential female leaders across diverse fields such as AI and big oil. Noteworthy mentions include women CFOs Sarah Friar at OpenAI and Amy Hood at Microsoft. A potential shortfall of magnetic rare earths by 2035 poses supply chain challenges for the U.S., compounded by recent Chinese export controls. The potential for a SpaceX IPO and data centers in space brings intriguing possibilities. While SpaceX's financial projections are ambitious, Elon Musk's history of innovation suggests potential for groundbreaking projects like space-based data centers. These satellite-based centers could cater to specific workloads, especially in AI-driven tasks, offering solutions amidst terrestrial zoning constraints. As we wrap up today's episode, these stories underscore major shifts in technology and business landscapes driven by innovation and strategic decisions across the globe. Stay tuned for more insights into how these developments unfold in the fast-paced world of AI and technology.Support the showThanks for listening! Follow us on Twitter, Instagram and Linkedin

Episode metadata supplied by the publisher feed · Published May 28, 2026

Embed this episode

Good morning from OWITH.ai, the podcast that gives you only what's important to hear in the AI and tech world. Demis Hassabis, CEO of Google DeepMind, is on a mission to revolutionize AI-driven drug discovery through his company, Isomorphic Labs. This AI drug discovery startup, spun out of Google in 2021, recently secured a $2.1 billion Series B funding round led by Thrive Capital. The capital aims to propel the company's next phase, focusing on scaling compute capabilities, generating more ...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Google DeepMind's $2.1B AI Drug Discovery Boost | OWITH Daily

0:00 3:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OWITH.ai - Only What's Important to Hear around AI and Tech?

This episode is 3 minutes long.

When was this OWITH.ai - Only What's Important to Hear around AI and Tech episode published?

This episode was published on May 28, 2026.

Can I download this OWITH.ai - Only What's Important to Hear around AI and Tech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!